Work on a national prescribing data set has allowed the NHS Business Services Authority (NHSBSA) to respond quickly to Covid-19 and helped GPs regain crucial time.
The NHSBSA has spent the last five years building a data ecosystem to improve many services it provides to the public.
The system pulls a massive amount of NHS data together including prescriptions data (45 million prescription forms are handled each month), drugs data and organisation data. The information is then tailored, so that the information is better able to meet the reporting and analysis needs of its users.
This data is then used by the NHS, Government, general public, academia and the private sector including pharmaceutical companies.
Andy Mason, Data Warehouse and BI Manager at the NHSBSA said: “NHSBSA has put years of expertise and effort into creating the prescribing base data. It was this hard work that created a data set which allowed us to act quickly in response to Covid-19.
“We are committed to using and sharing data appropriately and with the proper permissions in place.
“Looking after your data, understanding what data you have, how it should be stored, how it should be modelled, and how to unlock the power it possesses is so important for all organisations, but especially for those in healthcare.”
This has made a big difference to patients and GPs during the pandemic, by reducing footfall in GP surgeries and saving time. For example, the Electronic Repeat Dispensing (eRD) system has allowed GPs to give up to 12 months of prescriptions to suitable patients in one go. However, identifying suitable patients by using the systems GPs already had was time-consuming.
NHSBSA then worked with specialists at Wessex Academic Health Science Network and the wider Academic Health Science Network to identify patient criteria. NHSBSA is now able to share a full list of patients who are suitable for eRD with every single GP practice in England on request, using the prescribing data it has.
Graham Mitchell, Head of Provider Assurance at the NHSBSA said: “This has been a game changer and allowed GP practices to engage quickly with these patients, carry out clinical reviews, and introduce them to eRD.
“Our work has really paid off, resulting in 23 million extra eRD prescription items being issued from March 2020 to February 2021.”
To find out more about Electronic Repeat Dispensing click here.
